預防性醫療保健技術和服務市場：按服務類型、技術類型、最終用戶和地區分類。

Preventive Healthcare Technologies And Services Market, By Service Type, By Technology Type, By End User, By Geography

出版日期: 2026年03月27日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，預防性醫療保健技術和服務市場規模將達到3,386.1億美元，到2033年將達到7,030億美元。預計從2026年到2033年，該市場將以11.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	3386.1億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	11.00%	2033 年預計值：	7030億美元

近年來，全球預防性醫療保健技術和服務市場經歷了顯著成長。預防性醫療保健旨在透過預防疾病、健康惡化或損傷來促進健康。技術進步和公眾對醫療保健日益成長的關注正在擴大預防性醫療保健的範圍。影像、先進生物標記和基因檢測等各種技術使得疾病的早期檢測和風險評估成為可能。此外，數位健康解決方案的普及性支援遠端監測，並方便人們獲得預防性服務。隨著慢性病在全球的盛行率不斷上升，對預防性干預措施的需求也急劇增加。這推動了對創新預防性醫療保健模式和策略的研發投入。隨著人們對預防的重視程度不斷提高，預計未來幾年該市場將實現顯著成長。

市場動態

文明病率的上升、易患慢性病的老年人口不斷增加以及醫療保健成本的上漲，正在推動對預防性醫療技術和服務的需求。旨在改善公眾健康的各項政府計畫也支持這些解決方案的推廣應用。然而，實施先進的預防性技術和服務所需的大量投資是一個限制。開發價格合理的預防性解決方案為市場參與者提供了機會。此外，整合人工智慧等最尖端科技可望徹底改變預防醫學。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球預防醫療保健技術和服務市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
本研究涵蓋的主要公司包括 Healthlane、Abbott、GSK plc、Myriad Genetics、Omron Healthcare Inc.、Quest Diagnostics、Pfizer, Inc.、Merck & Co., Inc.、Omnicell、Novx Systems, Corp.、U-Systems, Ltd.、Viatronix, Inc.、Script., Inc.com, Inc.com, Inc., Inc.com 和 McKlonx, Inc.com.
本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球預防性醫療保健技術和服務市場涵蓋了該行業內各種各樣的相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球預防醫療保健技術和服務市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Healthlane
- Abbott
- GSK plc
- Myriad Genetics
- Omron Healthcare Inc.
- Quest Diagnostics
- Pfizer, Inc.
- Merck & Co., Inc.
- Omnicell
- Novx Systems, Corp.
- U-Systems, Ltd.
- Viatronix, Inc.
- Scripto LLC
- Lifecom, Inc.
- Dilon Medical Technologies, Inc.
- McKesson Corporation

第9章分析師觀點

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI6961

Preventive Healthcare Technologies And Services Market is estimated to be valued at USD 338.61 Bn in 2026 and is expected to reach USD 703 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 338.61 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.00%	2033 Value Projection:	USD 703 Bn

The global preventive healthcare technologies and services market has been witnessing significant growth in recent years. Preventive healthcare aims to prevent diseases, conditions or injuries and promote good health. Advancements in technologies and growing focus on population health management have expanded the scope of preventive care. Various technologies such as imaging, advanced biomarkers, and genetics have enabled early detection and risk assessment of diseases. In addition, the widespread adoption of digital health solutions is supporting remote monitoring and facilitating access to preventive services. As the prevalence of chronic diseases rises worldwide, the demand for preventive interventions is growing exponentially. This has prompted investments into the development of innovative preventive healthcare models and measures. The market is expected to grow substantially in the coming years as focus on prevention gains more prominence.

Market Dynamics

Rising incidence of lifestyle diseases, growing geriatric population susceptible to chronic illnesses and increasing healthcare costs associated with treatment are driving the demand for preventive healthcare technologies and services. Various government programmes aimed at population health are also boosting the adoption of these solutions. However, high investment requirements for the deployment of advanced preventive technologies and services act as a restraint. Developing affordable preventive solutions represents an opportunity for market players. Integrating cutting-edge technologies, such as artificial intelligence, also holds potential to revolutionize preventive care.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global preventive healthcare technologies and services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Healthlane, Abbott , GSK plc, Myriad Genetics, Omron Healthcare Inc., Quest Diagnostics, Pfizer, Inc., Merck & Co., Inc., Omnicell , Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., Scripto LLC , Lifecom, Inc., Dilon Medical Technologies, Inc., and McKesson Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global preventive healthcare technologies and services market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive healthcare technologies and services market.

Market Segmentation

By Service Type (Revenue, USD Bn, 2021 - 2033)
Diagnostic Services
Wellness & Health Assessment Services
Telemedicine Services
Pharmacy Services
Others
By Technology Type (Revenue, USD Bn, 2021 - 2033)
Telemedicine
mHealth
Health Information Technology
Wearable Devices
Others
By End User (Revenue, USD Bn, 2021 - 2033)
Healthcare Providers
Healthcare Payers
Others
By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Healthlane
Abbott
GSK plc
Myriad Genetics
Omron Healthcare Inc.
Quest Diagnostics
Pfizer, Inc.
Merck & Co., Inc.
Omnicell
Novx Systems, Corp.
U-Systems, Ltd.
Viatronix, Inc.
Scripto LLC
Lifecom, Inc.
Dilon Medical Technologies, Inc.
McKesson Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Technology Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Brand and Pricing Analysis
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Preventive Healthcare Technologies And Services Market, By Service Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Diagnostic Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Wellness & Health Assessment Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Telemedicine Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pharmacy Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Preventive Healthcare Technologies And Services Market, By Technology Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Telemedicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
mHealth
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Health Information Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Wearable Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Preventive Healthcare Technologies And Services Market, By End User, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Healthcare Providers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Healthcare Payers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Preventive Healthcare Technologies And Services Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Healthlane
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Myriad Genetics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Omron Healthcare Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Quest Diagnostics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Omnicell
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novx Systems, Corp.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- U-Systems, Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Viatronix, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Scripto LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lifecom, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dilon Medical Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- McKesson Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies